Uncategorized


March 12, 2025

Government Shutdown Now likely?

By Joe Lieber

Moments ago, Senate Majority Leader Chuck Schumer (D-NY) stated that that Republicans don’t have the 60 votes in the Senate to pass the seven-month continuing resolution (CR), which some speculate could lead to a shutdown….

Read More >>

March 12, 2025

Guardant Health (GH): Next Steps on Shield

By John Leppard

With the Medicare rate for GH’s Shield colorectal cancer (CRC) screening test set to increase 62% on April 1 ($920 to $1,495) following designation yesterday as an Advanced Diagnostic Laboratory Test (ADLT) – in line…

Read More >>

March 11, 2025

DC Quick Takes: Shutdown, Tariffs, Taxes, Deficit, Debt Limit and Special Elections

By Joe Lieber

Below we give our quick thoughts on: 1) shutdown odds; 2) tariffs; 3) the tax bill; 4) extent deficit reduction is really in the cards; 5) the debt limit and how that is likely to…

Read More >>

March 10, 2025

[OSCR, ELV, CNC, HCA, THC]: Targeting Obamacare Program Integrity in Rulemaking and Legislation

By Beth Steindecker

With all eyes focused on whether Congress will extend the enhanced ACA subsidies or let them lapse – we remain optimistic of a middle ground (revision and extension) – we caution investors about the headline…

Read More >>

March 10, 2025

Capitol Policy Weekly: March 10-14: Shutdown / Govt. Spending Pushes Out Reconciliation Action

By Joe Lieber

The House and Senate will be focused on passing a continuing resolution (CR) to fund the government through September 30, the end of the fiscal year, before beginning a weeklong recess. We doubt there will…

Read More >>

March 7, 2025

(FLTR, DKNG, MGM, CZR) Sports Betting Update

By Joe Lieber

Sports betting companies such as FLTR, DKNG, MGM and CZR received negative news today when legislation to legalize sports gambling was killed in Georgia. In addition, there is the risk of tax hikes on these…

Read More >>

March 5, 2025

Life Science Tools: Court Intervention & NIH’s New Management

By John Leppard

Events today support our view that NIH grant funding benefitting life science tools (LST) manufacturers will likely stabilize, and that the Trump administration’s Feb. 7 announcement of a 15% cap on indirect costs for all…

Read More >>

March 5, 2025

Diving Deeper on Outlook for Hospital-Targeted Medicaid Reforms [ARDT, CYH, HCA, THC, UHS, municipal-backed hospitals]

By Beth Steindecker

We do not see any let-up any time soon on policy-related headwinds confronting hospitals [ARDT, CYH, HCA, THC, UHS, municipal-backed systems] as Congress hunts for palatable reconciliation savings. While many of the circulated Medicaid ideas,…

Read More >>

March 3, 2025

Capitol Policy Weekly: March 3-7: State of the Union (Like) Address, Trade, Budget, Reconciliation, a Shutdown and More

By Joe Lieber

There is a lot going on in DC this week as Washington and Europe continue to digest the fallout from the Trump / Vance / Zelenskyy Oval Office disaster on Friday. On the list includes…

Read More >>

March 3, 2025

[DXCM, OMI, AHCO] Glucose Monitors in the Crosshairs?

By John Leppard

We anticipate risks for manufacturers [DXCM, ABT] and suppliers [OMI, AHCO] of continuous glucose monitors (CGM) beginning this spring / summer, given that: The HHS Office of Inspector General (OIG) will likely publish the results…

Read More >>